Unlike BPC-157, which has been in the Canadian market for years and is relatively difficult to fake because the market norms are well-established, retatrutide is newer
Older adults may also be more sensitive to these side effects and could require extra care
OBES SURG 27(11):29332939 Noparatayaporn P, Thavorncharoensap M, Chaikledkaew U, Bagepally BS, Thakkinstian A (2021) Incremental net monetary benefit of bariatric surgery: systematic review and meta-analysis of cost-effectiveness evidences
Flow Wellness does not claim affiliation with or endorsement by Novo Nordisk or Eli Lilly.
This can be more convenient for those with busy schedules
"Lilly's triple agonist, retatrutide, delivered weight loss of up to an average of 71.2 lbs along with substantial relief from osteoarthritis pain in first successful Phase 3 trial." Eli Lilly and Company , 11 Dec